Introduction
A significant concern in heart failure (HF) is the development of neural injury, exemplified by both gray and white matter damage, which appears in brain areas that mediate autonomic, neuropsychologic, and cognitive regulation, resulting in serious impairments of those functions.
1 -3 The neural damage appears on evaluation by several magnetic resonance imaging (MRI) procedures, and is reflected as regional loss of tissue or injury, as measured by manual assessment, 2 3 and diffusion tensor imaging 4 procedures. The injury is preferentially unilateral, and principally on the right side, although left-side damage also appears. Since the injury can result in impaired physiological functions, such as autonomic dysregulation, the potential for damage to further exacerbate the HF condition is a significant concern. However, the underlying processes inducing brain tissue injury in these areas are unclear; low cardiac output and intermittent hypoxia from disturbed breathing in the condition may contribute, but distorted haemodynamic characteristics likely advance damage as well. Brain sites that show tissue injury in HF subjects include cingulate, insular, hypothalamic, hippocampal, amygdala, brainstem, and cerebellar areas; 1,3,4 thus, if injury stems from altered cerebrovascular regulation, the impaired modulation should be reflected in abnormal cerebral blood flow (CBF) near those areas. Cerebrovascular autoregulation, a central autonomic control mechanism by which CBF remains constant despite changes in systemic blood pressure or body position, 5 is abnormal in HF subjects, establishing a potential for injury if activated tissue is inadequately perfused. 6, 7 Although localized injury likely develops from altered haemodynamic patterns in the vasculature near affected tissue, little information on such regional CBF is available in HF subjects.
T2-relaxometry
Magnetic resonance imaging procedures that can assess CBF across the brain include arterial spin labelling (ASL) and dynamic contrast-based perfusion imaging. Arterial spin labelling-based perfusion MRI is a non-invasive approach, and does not use radiation or contrast agents to assess regional brain perfusion changes. Instead, the procedure uses magnetically-labelled arterial blood water as an endogenous tracer. The non-invasive nature of ASL is appealingly safe, as opposed to adverse effects from contrast use, and is especially suitable for patients with poor intravenous access and renal dysfunction, both of which are common in HF subjects. Arterial spin labelling-based CBF measurements have been validated using 15 O-water positron emission tomography, and are reproducible over short and long periods, making it favorable for disease identification, tracking disease progression, and treatment effects. The procedures have been used effectively in various disease conditions, including ischaemia, 8 Alzheimer disease, 9 12 and may facilitate regional evaluation of brain perfusion non-invasively in HF subjects.
Our aim was to assess regional CBF changes in HF over control subjects using non-invasive ASL procedures. We hypothesized that HF patients would show reduced CBF in various brain sites that earlier showed injury, and which help regulate functions deficient in the condition.
Methods

Subjects
Nineteen HF patients and 29 control subjects were included in this study. The demographics and other variables of all subjects are tabulated in Table 1 . All HF patients were diagnosed based on national diagnostic criteria, showed systolic dysfunction and dilated cardiomyopathy, and were recruited from the Ahmanson-University of California at Los Angeles (UCLA) Cardiomyopathy Center. Of 19 HF subjects, 9 subjects were with ischaemic and 10 with non-ischaemic etiologies. Among 19 HF subjects, 12 subjects were hypertensive, 4 subjects with atrial fibrillation, and 5 subjects had a history of type 2 diabetes. All HF subjects had reduced ejection fraction and were classified as New York Heart Association (NYHA) functional class II (80%) and III (20%). Heart failure patients in NYHA functional class IV were excluded, since subjects with such classifications cannot lay supine in the MRI scanner for sustained periods. Heart failure patients used stable guideline-directed doses (titrated to reach targeted haemodynamic goals) of angiotensin receptor blockers (n = 6) or angiotensin-converting enzyme inhibitors (n = 15), beta blockers (n = 17), and diuretics (n = 16), and excess fluid volume status was alleviated for at least six months before collecting MRI data. None of the HF patients had evidence or history of alcohol-induced cardiomyopathy or diastolic failure, valvular congenital heart defects, drug abuse, stroke or carotid vascular disease, or head injury. Control subjects were recruited through advertisements at the UCLA hospital system and Los Angeles area. Control subjects were healthy, without any clinical history of cardiovascular disease, stroke, respiratory deficits, renal dysfunction, drug abuse, neurological or psychiatric conditions, and use of cardiac or psychotropic medications that may introduce brain injury. Since control subjects were not taking any cardiac medications and showed no signs of cardiovascular issues, subjects were not examined with echocardiography. All control and HF subjects with claustrophobia, inability to lay supine, carrying non-removable metal, embolic coils, pacemakers/implantable cardioverter-defibrillators, or stents, were excluded. Control and HF subjects provided written informed consent before the study, and the study protocol was approved by the Institutional Review Board at UCLA.
Sleep quality and daytime sleepiness examination
Sleep quality for all subjects was assessed with the Pittsburgh sleep quality index (PSQI), and daytime sleepiness with the Epworth sleepiness scale (ESS). 13, 14 The PSQI and ESS tests are self-administered questionnaires, and were performed either immediately before or after the MRI study for evaluation of sleep quality and daytime sleepiness. 13, 14 
Assessment of depression and anxiety
All HF and control subjects were assessed for depression and anxiety using the Beck depression inventory (BDI-II) and the Beck anxiety inventory (BAI), respectively. 15, 16 The BDI-II and BAI inventories are self-administered questionnaires (21 questions; each score 0-3), which were introduced either immediately before or after MRI examination, with total scores ranging from 0-63 based on symptom severity. 15, 16 Cognitive examination All HF and control subjects underwent the Montreal Cognitive Assessment (MoCA) test, 17 for rapid evaluation of cognitive domains, including attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation. A global MoCA score ≥26 is considered normal. 17 
Magnetic resonance imaging
All brain studies were performed in a 3.0-Tesla MRI scanner (Siemens, Magnetom Tim-Trio, Erlangen, Germany), using a receive-only eight-channel phased-array coil, and body coil as a transmitter coil. Subjects lay supine inside the scanner, and foam pads were used on both sides of the head to minimize head motion during data acquisition. Two high-resolution T1-weighted images were collected using a magnetization-prepared rapid acquisition gradient-echo pulse sequence [repetition-time (TR) = 2200 ms; echo-time (TE) = 2.34 ms; inversion time = 900 ms; flip angle (FA) = 9 ∘ ; matrix size = 320 × 320; field-of-view (FOV) = 230 × 230 mm 2 ; slice thickness = 0.9 mm). Proton density (PD) and T2-weighted
imaging (TR = 10 000 ms; TE1,2 = 12, 123 ms; FA = 130 ∘ ; matrix size = 256 × 256; FOV = 230 × 230 mm 2 ; slice thickness = 3.5 mm) were performed, covering the entire brain in the axial plane using a dual-echo turbo spin-echo pulse sequence. Arterial spin labelling scans were collected using a pseudo-continuous ASL pulse sequence in the axial plane (TR = 4000 ms; TE = 11 ms; FA = 90 ∘ ; bandwidth = 3004 Hz/pixel; label-offset = 90 mm; label delay = 1200 ms; matrix size = 64 × 64; FOV = 230 × 230 mm 2 ; slice thickness = 3.5 mm; distance factor = 20%; slices = 38; repeats = 40).
Data processing and analyses
We used the statistical parametric mapping package (SPM12, http:// www.fil.ion.ucl.ac.uk/spm/), MRIcroN, and MATLAB-based (The MathWorks Inc., Natick, MA, USA) custom software for data processing and analyses.
We visually examined high-resolution T1-, PD-, and T2-weighted images of all subjects for any serious brain pathology, such as tumours, cysts, or major brain infarcts. Arterial spin labelling images were also examined for any potential head motion-related or other imaging artifacts. None of the subjects included in this study showed any such brain pathology or imaging artifacts, which may affect regional CBF values.
Calculation of cerebral blood flow maps
Labelled and non-labelled ASL brain volumes were realigned to remove any potential head motion-related variations. Using labelled and non-labelled echo planar imaging (EPI) scans, perfusion images were calculated with simple subtractions from non-labelled to labelled images. Perfusion images were used to calculate whole-brain CBF maps, as described elsewhere. 18 
Normalization and smoothing of cerebral blood flow maps
The mean EPI images of each individual subject were segmented into gray, white, and cerebrospinal fluid tissue types, and a 4D file that contained warping parameters (3D file for each direction) was generated using the modified unified segmentation approach implemented in SPM12. 19 Mean CBF, gray and white matter probability maps of the corresponding subject were transformed to Montreal Neurological Institute (MNI) space using the normalization parameters obtained earlier. The normalized CBF maps were smoothed using a Gaussian filter (kernel, 8 mm).
We also normalized high-resolution T1-weighted images of a control subject to MNI space and removed cerebrospinal fluid and other non-brain regions. The resulting images were used as background images for structural identification.
probability maps from all subjects were averaged. The averaged gray and white matter probability maps were thresholded (white matter probability > 0.3, gray matter probability > 0.3), and combined to create a global brain mask.
Statistical analysis Demographics and other variables
The Statistical Package for the Social Sciences (SPSS, v20.0, New York, NY, USA) software was used for assessment of demographic, biophysical, physiological, mood, sleep, and cognitive variables between groups using Chi-square and independent samples t-tests. A P-value of <0.05 was considered statistically significant.
Regional cerebral blood flow changes
The smoothed CBF maps were compared voxel-by-voxel between HF and control subjects using analysis of covariance (ANCOVA; SPM12; covariates, age, gender, and global gray matter volume; uncorrected threshold, P < 0.005). The global brain mask was used to limit the analysis to brain regions only. Brain clusters with significant differences between groups were overlaid onto background images for structural identification.
Regional cerebral blood flow values
Binary masks of each individual brain regions, which showed significant differences between groups based on whole-brain voxel-based analyses, were created, and regional CBF values were calculated using the normalized and smoothed CBF maps with MATLAB-based custom-written software. Regional CBF values were compared between groups using ANCOVA, with age, sex, and global gray matter volume included as covariates to examine significant differences and effect sizes between groups on those sites. A P-value of < 0.05 was chosen to establish statistical significance.
Results
Demographics and other variables
Demographic, biophysical, physiological, mood, sleep, and cognitive data of HF and control subjects are summarized in Table 1 . No significant differences in age, gender, body mass index (BMI), or heart rate emerged between HF and control subjects (age, P = 0.09; gender, P = 0.65; BMI, P = 0.12; heart rate, P = 0.85). However, both systolic (P = 0.005) and diastolic (P = 0.02) blood pressure values were significantly lower in HF over control subjects. PSQI scores were significantly higher in HF (P = 0.02) over controls; however, ESS scores showed no significant differences. Heart failure patients had significantly higher BDI-II (P = 0.004) scores as compared to controls. Global MoCA scores were significantly lower in HF patients compared to controls (P = 0.02), with significant differences in delayed recall scores (P = 0.003). Also, global gray matter volume significantly differed between HF and control subjects (P = 0.01). occipital, temporal, frontal, and parietal regions ( Figure 1) . Sites with lower CBF values in HF patients emerged in the bilateral prefrontal cortex, extending through frontal white matter and the left anterior corpus callosum. Bilateral anterior thalamus, dorsal hippocampus, amygdala, and occipital cortex showed lower CBF values in HF patients. The reduced flow was remarkable for the dorsal temporal and occipital white matter regions, along with principally right-sided appearance in corona radiate, superior parietal, mid-temporal, and mid-occipital cortices; bilateral cerebellar vermis and anterior cerebellar cortex, extending to left posterior cerebellar cortex (Figures 2 and 3) . A few sites with limited clusters, including the bilateral inferior frontal white matter, showed increased CBF values in HF patients over controls.
Regional cerebral blood flow changes
Regional cerebral blood flow values
Regional CBF values of HF and control subjects are summarized in Table 2 . All brain sites showed significant reductions in HF patients over controls ( Table 2) .
Discussion
Regional CBF reduction in HF patients appeared in multiple brain sites, and those regions included vascular beds over the frontal, parietal, and occipital cortices, hippocampus, thalamus, and cerebellar areas; the majority of these brain sites also show brain tissue injury, based on previous studies. 1,3 A remarkable aspect is laterality of the CBF reduction, with the principal decline on the right side, appearing in cortical, and diencephalic areas; other areas showed bilateral CBF reductions, especially in the cerebellum and corona radiate. The decreased regional CBF may contribute to tissue injury in affected areas, and participate in the autonomic, neuropsychologic, and cognitive regulatory deficits found in the condition.
Reduced cerebral blood flow in autonomic regulatory sites
Autonomic nervous system abnormalities, including exaggerated sympathetic tone, excessive catecholamine outflow, impaired dynamic responses to cardiovascular challenges, and altered fluid regulation, are hallmarks of HF, and are present in nearly all persons with this condition. 20 -23 Multiple brain autonomic regulatory sites showed reduced CBF in HF patients, and include the hippocampus, thalamus, corona radiate and cerebellar sites. The affected structures also show abnormal functional MRI signal responses to autonomic and cardiovascular challenges in HF. 24 Structural injury has been identified in these brain sites by various MRI procedures, and the overlap of regional CBF reduction and injury suggests significant relationships between perfusion changes and brain tissue integrity. The cerebellar cortex, although usually implicated in movement control, is now recognized as playing major roles in blood pressure regulation, especially in coordinating blood pressure changes with motion or dampening extremes of blood pressure. 25 neurons of the fastigial nuclei, which project to brainstem and rostral brain sites that regulate sympathetic nervous outflow. The cerebellum coordinates motor patterning for smooth execution of voluntary movements and acquisition of motor behaviours along with coordination of breathing, 28 and respiratory timing interactions with momentary blood pressure changes, and integration of essential cardiovascular control processes, including the baroreflex and chemoreflex. 29 Thus, reduced CBF in cerebellar sites has the potential to significantly influence autonomic patterning and contribute substantially to cardiovascular control deficits in HF.
Altered cerebral blood flow values in mood regulatory sites
Heart failure patients exhibit high levels of mood symptoms, 30 which can impede self-care and lead to deterioration of quality of life. In this study, both depression and anxiety symptoms were significantly increased in HF patients. Brain sites associated with mood regulation include the prefrontal cortex, cingulate, insula, hippocampus, amygdala, and cerebellar areas. 3 These brain sites have been associated with injury in subjects with depression only; 31 however, the majority of these areas also showed reduced CBF here in HF patients. The amygdala is also involved in anxiety regulation, and the bilateral amygdalae showed reduced CBF here. Reduced CBF in these regions likely contribute to tissue changes, and thus, have the potential to modify levels of depressive and anxiety symptoms in HF patients.
Altered cerebral blood flow in cognitive regulatory regions
Brain sites that regulate short-term memory and decision-making executive functions, including the hippocampus and prefrontal cortex, showed CBF changes in HF patients. The affected areas include large collections of nerve fibres; the corpus callosum serves verbal memory functions, among other actions, and the corona radiate are associated with intellectual, social, and emotional functioning. The hippocampus sends information to the mammillary bodies through the fornix fibers, and the mammillary bodies project to the anterior thalamus, from which information is distributed to cortical and other sites; 32 the CBF reduction is particularly shown in Figures 2 and 3 . Although altered CBF appeared only on hippocampal regions and the thalamus, structural injury emerged on the majority of these sites as noted on previous studies, 33, 34 and tissue injury in this memory circuitry can affect memory processing issues accompanying the condition. Our previous studies showed hippocampal volume loss in HF, predominantly in the CA1 subregion and hippocampal-mammillary body circuitry, leading to impaired anterograde and spatial memory functions. 34 Short-term memory loss is one of the most common cognitive issues in HF, with an incidence ranging from 23-80% in the condition. 35 ability to learn and carry out essential self-management strategies, such as accurately and appropriately following dietary and medication regimens, recognizing symptoms associated with deteriorating health, and communicating clearly with a health care provider. 35, 36 The loss of memory and learning abilities to self-manage HF increases the risk for HF exacerbations and associated morbidity and mortality in this condition. Cerebral blood flow reductions appeared in the prefrontal cortex, a structure which plays critical roles in cognitive actions, including executive decision-making. The region sends and receives information from cortical sensory, sub-cortical, and motor areas, including the caudate nuclei and putamen; changes in this site may contribute to altered decision making functions in the condition.
Executive decision-making includes initiating, maintaining, and ceasing actions to organize behaviours toward a specific target with abstract and conceptual thinking. These functions are impaired in HF, and can afflict 19-50% of these patients. 37 The prefrontal cortex is the most common brain region associated with impaired executive decision-making, 38 and damage shows a form of "psychological inertia" (inability to stop or change a behaviour), which can impede important self-care behaviours, deficient in HF.
superior parietal, mid-temporal and mid-occipital cortices, which help regulate these deficient functions, 43 -45 showed reduced CBF in HF patients. Temporal cortical areas that play significant roles in speech control, 43 and tissue under the superior parietal regions that regulate language 44 show reduced CBF in HF patients. Other cortical sites that control visual domains include mid-occipital, lingual, precuneus, and superior parietal cortex. 45 Altered CBF in these visual and language regulatory areas may contribute to impaired functionality.
Reduced cerebral blood flow in various white matter regions
Reduced CBF in white matter regions are associated with poorer cognitive function, may put individuals at risk for development of dementia, and are more prevalent among certain psychiatric disorders. 9 Further, an inverse association exists between cardiac output and white matter hyperintensities, suggesting that systemic hypoperfusion may increase the risk for development of hyperintensities, 46 and might lead to lower CBF on those white matter regions. 47 
Potential mechanisms for reduced regional cerebral blood flow
Precise mechanisms that may contribute to decreased regional CBF in HF are unknown, but may include low cardiac output, endothelial dysfunction, ischaemic changes and disruption of cerebral autoregulation. Low cardiac output is characteristic of HF, leading to ischaemia, which affects both tissue and vasculature, altering endothelial function. Altered endothelial function can contribute to abnormal cerebral autoregulation, reflected as decreased CBF in HF patients. Cerebral autoregulation is affected by exaggerated sympathetic activity 48 and the renin-angiotensin system, which is a central neurohormonal response to maintain cardiac output and systemic haemodynamics. 49 Endothelin concentration, a vasoconstrictive peptide, might increase from disturbed neurohormonal activity and consequently increases vascular resistance of cerebral vascular bed and reduces CBF. 50, 51 Exacerbated neurohormonal system releases B-type natriuretic peptide, a marker of HF severity, as a response to increase ventricular wall stretch and may cause distortion of autoregulation and reduced CBF. 52 Both endothelin 53 and B-type natriuretic peptide 54 neurohormones play an important role in endothelial dysfunction. Cerebral autoregulation maintains a stable CBF over a wide range of mean arterial pressure; however, HF-induced activation of neurohormonal systems may play a crucial role in distorting autoregulation. 55 All our HF patients had reduced systolic left ventricular function, which decreases perfusion pressure, and thus, can potentially reduce CBF. 56 Cardiomyopathic rabbits show CBF reduction following chronic low cardiac output. 49 Heart failure is accompanied by reduced end-respiratory CO 2 concentrations that reduce the partial pressure of blood CO 2. Lower CO 2 contributes to reduced cerebral arteriolar dilatation, which leads to reduced CBF. 48, 55 Though 80% of our HF patients were on angiotensin-converting enzyme inhibitors, which maintain or increase CBF in HF, 57 60, 61 Mild non-ischaemic HF patients showed significant changes in basilar inflow volume, cerebral autoregulation and vasomotor reactivity, although the small sample size precluded CBF to reach significant levels. 62 
Limitations
Several limitations of this study should be acknowledged. Some brain sites, including the cerebellar regions, temporal white matter, and corona radiate showed significant dispersion in CBF values in a few HF patients. However, other sites showed minimal dispersion, which encouraged us to include these subjects in the analyses. Also, HF patients showed significant low blood pressure as compared to controls. Those differences in blood pressure may contribute to compromised CBF; further studies are needed to explore the influence of this issue.
Conclusions
Heart failure patients show decreased regional CBF values in several brain regions compared to control subjects. The reduced CBF in HF patients appeared over prefrontal, parietal, and occipital cortices, corpus callosum, temporal regions, thalamus, hippocampus, amygdala and cerebellar regions that control autonomic, cognitive, and mood functions. The pathological processes that contribute to decreased regional CBF in HF are unknown, but may include reduced cardiac outflow commonly found in the condition, as well as increased sympathetic influences on the local cerebral vascular bed from the overall exaggerated sympathetic tone.
